Entera Bio Ltd. (ENTX) Misses Q2 EPS by 5c

Entera Bio Ltd. (NASDAQ: ENTX) reported Q2 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Entera Bio Ltd. (ENTX) click here.

You May Also Be Interested In

• Antero Resources (AR) PT Raised to $47 at Benchmark on Natural Gas Bull Case
• Terreno Realty Corp (TRNO) PT Raised to $75 at KeyBanc on 'Improving Demand'
• China approves ivonescimab plus chemo for squamous NSCLC